MSLN and ovarian carcinoma: Another example of an anti-cancer CAR γδ T cell is the anti-mesothelin CAR Vδ2 T cell enhanced with increased CD16 expression to augment ADCC, with or without additional increased IL-15 expression, for targeting ovarian cancers [210].